Shapiro; Joseph I.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Shapiro; Joseph I..The latest application filed is for "compositions and methods for treating pulmonary hypertension".

Company Profile

3.17.24

Shapiro; Joseph I. - Huntington WV
Shapiro; Joseph I. - Toledo OH
Shapiro; Joseph I - Toledo OH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating obesity Grant 11,311,600 - Xie , et al. April 26, 2	2022-04-26
Compositions and methods for treating pulmonary hypertension Grant 11,220,528 - Xie , et al. January 11, 2	2022-01-11
Compositions and methods for treating retinopathy Grant 10,973,867 - Xie , et al. April 13, 2	2021-04-13
Compositions And Methods For Treating Pulmonary Hypertension App 20200165299 - Xie; Zijian ; et al.	2020-05-28
Compositions And Methods For Treatment Of Uremic Cardiomyopathy App 20200085918 - XIE; Zijian ; et al.	2020-03-19
Compositions And Methods For Treating Retinopathy App 20200030404 - XIE; Zijian ; et al.	2020-01-30
Methods For Treating Obesity App 20180353569 - XIE; Zijian ; et al.	2018-12-13
Methods of treatment of cancer using SRC-modulating peptides Grant 9,663,561 - Xie , et al. May 30, 2	2017-05-30
Na/K-ATPase ligand and uses thereof in wound healing Grant 9,492,463 - Xie , et al. November 15, 2	2016-11-15
Na/K-ATPase-derived peptide Src inhibitors and ouabain antagonists and uses thereof Grant 9,226,952 - Xie , et al. January 5, 2	2016-01-05
Na/K-ATPase Ligand and Uses Thereof in Wound Healing App 20150342966 - Xie; Zi-Jian ; et al.	2015-12-03
Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof App 20150272923 - Xie; Zi-Jian ; et al.	2015-10-01
Na/K-ATPase ligands, ouabain antagonists, assays and uses thereof Grant 9,114,126 - Xie , et al. August 25, 2	2015-08-25
Assays and Cell-Based Tests Using a Receptor Na/K-ATPase/Src Complex and Uses Thereof App 20150233925 - Xie; Zi-Jian ; et al.	2015-08-20
Na/K-ATPase ligand Grant 9,072,751 - Xie , et al. July 7, 2	2015-07-07
Na+/K+-ATPase-Specific Peptide Inhibitors/Activators of Src and Src Family Kinases App 20150133389 - Xie; Zi-Jian ; et al.	2015-05-14
Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases Grant 8,981,051 - Xie , et al. March 17, 2	2015-03-17
Na/K-ATPase ligand Grant 8,906,891 - Xie , et al. December 9, 2	2014-12-09
Na/k-atpase-derived Peptide Src Inhibitors And Ouabain Antagonists And Uses Thereof App 20140187484 - Xie; Zi-Jian ; et al.	2014-07-03
Na/K-ATPase Ligand App 20140128356 - Xie; Zi-Jian ; et al.	2014-05-08
Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof App 20140031419 - Xie; Zi-Jian ; et al.	2014-01-30
Na+/K+-ATPase-Specific Peptide Inhibitors/Activators of Src and Src Family Kinases App 20130150294 - Xie; Zi-Jian ; et al.	2013-06-13
Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof App 20120302630 - Xie; Zi-Jian ; et al.	2012-11-29
Na+K+-ATPase-specific peptide inhibitors/activators of SRC and SRC family kinases Grant 8,283,441 - Xie , et al. October 9, 2	2012-10-09
Peg-albumin composition having at least one protected thiol region as a platform for medications App 20120010144 - Assaly; Ragheb ; et al.	2012-01-12
NaK-ATPase-Derived Peptide SRC Inhibitors and Ouabain Antagonists and Uses Thereof App 20110245167 - Xie; Zi-Jian ; et al.	2011-10-06
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use Grant 7,884,068 - Assaly , et al. February 8, 2	2011-02-08
NA+K+-ATPase-Specific Peptide Inhibitors/Activators of SRC and SRC Family Kinases App 20100056446 - Xie; Zijian ; et al.	2010-03-04
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction App 20100004178 - Assaly; Ragheb ; et al.	2010-01-07
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction Grant 7,605,130 - Assaly , et al. October 20, 2	2009-10-20
Na/K-ATpase Ligand App 20090226513 - Xie; Zijian ; et al.	2009-09-10
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use App 20080247958 - Assaly; Ragheb A. ; et al.	2008-10-09
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction App 20080113903 - Assaly; Ragheb ; et al.	2008-05-15
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction Grant 7,348,312 - Assaly , et al. March 25, 2	2008-03-25
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use Grant 7,345,150 - Assaly , et al. March 18, 2	2008-03-18
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction App 20060166886 - Assaly; Ragheb ; et al.	2006-07-27
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction Grant 7,037,895 - Assaly , et al. May 2, 2	2006-05-02
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use App 20060057070 - Assaly; Ragheb A. ; et al.	2006-03-16
Albumin-based colloid composition having at least one protected thiol region, methods of making, and methods of use App 20050187139 - Assaly, Ragheb A. ; et al.	2005-08-25
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction App 20030004105 - Assaly, Ragheb A. ; et al.	2003-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.